Get all your news in one place.
100's of premium titles.
One app.
Start reading
International Business Times
International Business Times
Carla St. Louis

Biopharmaceutical Company's Stock Plunges 75% After FDA Rejects New Drug

WHITE OAK, MD - JULY 20: A sign for the Food And Drug Administration is seen outside of the headquarters on July 20, 2020 in White Oak, Maryland. (Credit: Sarah Silbiger/Getty Images)

Applied Therapeutics' stock plummeted 75 percent after the Food and Drug Administration (FDA) rejected approving govorestat as a treatment for galactosemia.

The stock closed at $2.03, reported Yahoo Finance.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.